- Home
- JTAI vs KZIA Comparison
JTAI vs KZIA Comparison
Compare JTAI & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JTAI
- KZIA
- Stock Information
- Founded
- JTAI 2018
- KZIA 1994
- Country
- JTAI United States
- KZIA Australia
- Employees
- JTAI N/A
- KZIA N/A
- Industry
- JTAI Blank Checks
- KZIA Biotechnology: Pharmaceutical Preparations
- Sector
- JTAI Finance
- KZIA Health Care
- Exchange
- JTAI Nasdaq
- KZIA Nasdaq
- Market Cap
- JTAI 8.3M
- KZIA 9.0M
- IPO Year
- JTAI N/A
- KZIA 1999
- Fundamental
- Price
- JTAI $3.19
- KZIA $8.00
- Analyst Decision
- JTAI Strong Buy
- KZIA Strong Buy
- Analyst Count
- JTAI 1
- KZIA 2
- Target Price
- JTAI $11.00
- KZIA $14.00
- AVG Volume (30 Days)
- JTAI 40.5K
- KZIA 136.9K
- Earning Date
- JTAI 08-15-2025
- KZIA 06-05-2025
- Dividend Yield
- JTAI N/A
- KZIA N/A
- EPS Growth
- JTAI N/A
- KZIA N/A
- EPS
- JTAI N/A
- KZIA N/A
- Revenue
- JTAI $12,790,684.00
- KZIA $1,549,158.00
- Revenue This Year
- JTAI $13.37
- KZIA N/A
- Revenue Next Year
- JTAI $201.13
- KZIA $49.25
- P/E Ratio
- JTAI N/A
- KZIA N/A
- Revenue Growth
- JTAI N/A
- KZIA 248983.08
- 52 Week Low
- JTAI $2.30
- KZIA $2.86
- 52 Week High
- JTAI $57.17
- KZIA $39.05
- Technical
- Relative Strength Index (RSI)
- JTAI 46.25
- KZIA 49.43
- Support Level
- JTAI $3.09
- KZIA $7.60
- Resistance Level
- JTAI $3.26
- KZIA $8.88
- Average True Range (ATR)
- JTAI 0.14
- KZIA 0.59
- MACD
- JTAI 0.00
- KZIA 0.06
- Stochastic Oscillator
- JTAI 30.95
- KZIA 48.57
About JTAI Jet.AI Inc.
Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as through Jet Token's leased and managed aircraft.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.